Literature DB >> 24907206

Atrioventricular block related to liposomal amphotericin B.

Bruno Fernandes Sanches1, Pedro Nunes2, Helena Almeida2, Mónica Rebelo3.   

Abstract

Atrioventricular block can occur in normal children, young adults or athletes. It is also associated with underlying heart disease or occurs as a drug adverse effect. Amphotericin B is used in the treatment of invasive fungal infections. Cardiac toxicity is a rare adverse reaction. We report the case of a 9-month girl, admitted in the paediatric intensive care unit with cytomegalovirus pneumonitis. During hospitalisation the patient developed a systemic fungic infection and was medicated with liposomal amphotericin B. On the third day of treatment she began repeated episodes of bradycardia with spontaneous reversion. The investigation revealed a second-degree atrioventricular block. We excluded the misplacement of the central catheter, myocarditis or structural cardiomyopathy and suspended amphotericin. After 8 days, the bradycardia episodes ceased what was consistent with the drug's half-life. Amphotericin cardiotoxic mechanism is still unclear. It may be related with alteration of myocardial membrane depolarisation. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24907206      PMCID: PMC4054472          DOI: 10.1136/bcr-2013-202688

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  25 in total

1.  Mechanical complications of central venous catheters.

Authors:  Lewis A Eisen; Mangala Narasimhan; Jeffrey S Berger; Paul H Mayo; Mark J Rosen; Roslyn F Schneider
Journal:  J Intensive Care Med       Date:  2006 Jan-Feb       Impact factor: 3.510

Review 2.  Complications of central venous catheterization.

Authors:  Roberto E Kusminsky
Journal:  J Am Coll Surg       Date:  2007-04       Impact factor: 6.113

3.  Effects of amphotericin B on isolated rabbit hearts.

Authors:  E Rutz-Ceretti; O F Schanne; J L Bonnardeaux
Journal:  J Mol Cell Cardiol       Date:  1976-01       Impact factor: 5.000

4.  The effects of amphotericin B on the ionic currents on frog atrial trabeculae.

Authors:  O F Schanne; E Ruiz-Ceretti; Y Deslauriers; D Payet; P Soulier; J M Demers
Journal:  J Mol Cell Cardiol       Date:  1977-11       Impact factor: 5.000

5.  Arrhythmia caused by amphotericin B in a neonate.

Authors:  J H Googe; J N Walterspiel
Journal:  Pediatr Infect Dis J       Date:  1988-01       Impact factor: 2.129

Review 6.  Congenital complete heart block: an international study of the natural history.

Authors:  M Michaëlsson; M A Engle
Journal:  Cardiovasc Clin       Date:  1972

Review 7.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

8.  Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.

Authors:  Ihor Bekersky; Robert M Fielding; Dawna E Dressler; Jean W Lee; Donald N Buell; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

9.  Amphotericin B: time for a new "gold standard".

Authors:  Luis Ostrosky-Zeichner; Kieren A Marr; John H Rex; Stuart H Cohen
Journal:  Clin Infect Dis       Date:  2003-07-22       Impact factor: 9.079

10.  Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults.

Authors:  Neil E Bowles; Jiyuan Ni; Debra L Kearney; Matthias Pauschinger; Heinz-Peter Schultheiss; Robert McCarthy; Joshua Hare; J Timothy Bricker; Karla R Bowles; Jeffrey A Towbin
Journal:  J Am Coll Cardiol       Date:  2003-08-06       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.